{
  "id": "e936e1a3-1114-426f-927a-186a92287d66",
  "description": "SAN DIEGO, June 22, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY) today announced the closing of its initial public offering of 7,666,664 shares of common stock, including the full exercise of the underwriters’ option to purchase up to 999,999 additional shares of common stock, at a public offering price of $16.00 per share. The aggregate gross proceeds to Codex DNA from the offering were approximately $122.7 million, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were offered by Codex DNA. \n\nCodex DNA’s common stock began trading on The Nasdaq Global Select Market on June 18, 2021 under the ticker symbol \"DNAY.\"\n\nJefferies LLC, Cowen and Company, LLC and KeyBanc Capital Markets Inc. are acting as joint book-running managers for the proposed offering.",
  "type": "IPO",
  "title": "Codex DNA IPO",
  "date_of": "2021-06-23",
  "link": "https://www.globenewswire.com/news-release/2021/06/22/2251361/0/en/Codex-DNA-Announces-Closing-of-Initial-Public-Offering-and-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares.html",
  "location": "San Diego",
  "value": 123000000,
  "other_info": {
    "event_id": "01FNWJJAABXYNM1KC9SDS7GKCN",
    "event_type": "form_response",
    "form_response": {
      "token": "i98hkcbgv4li5sad6i98hkcbdqwzm4hu",
      "answers": [
        {
          "text": "Codex DNA IPO",
          "type": "text",
          "field": {
            "id": "q3QmKAzJYGzq",
            "ref": "b2eeb462-1500-4d36-a198-3de54ec14b00",
            "type": "short_text"
          }
        },
        {
          "type": "choice",
          "field": {
            "id": "B7iC0k4GVJsg",
            "ref": "d2188e47-cf07-44d3-9e27-9be707573ec4",
            "type": "multiple_choice"
          },
          "choice": {
            "label": "IPO"
          }
        },
        {
          "date": "2021-06-23",
          "type": "date",
          "field": {
            "id": "ba1GfT4AK1oH",
            "ref": "632265be-6f7a-47f2-8b55-54ddfce7d04d",
            "type": "date"
          }
        },
        {
          "text": "SAN DIEGO, June 22, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY) today announced the closing of its initial public offering of 7,666,664 shares of common stock, including the full exercise of the underwriters’ option to purchase up to 999,999 additional shares of common stock, at a public offering price of $16.00 per share. The aggregate gross proceeds to Codex DNA from the offering were approximately $122.7 million, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were offered by Codex DNA. \n\nCodex DNA’s common stock began trading on The Nasdaq Global Select Market on June 18, 2021 under the ticker symbol \"DNAY.\"\n\nJefferies LLC, Cowen and Company, LLC and KeyBanc Capital Markets Inc. are acting as joint book-running managers for the proposed offering.",
          "type": "text",
          "field": {
            "id": "a0y0vsT8mzNv",
            "ref": "8790717a-44fe-4a19-9b83-671c89ac657d",
            "type": "long_text"
          }
        },
        {
          "url": "https://www.globenewswire.com/news-release/2021/06/22/2251361/0/en/Codex-DNA-Announces-Closing-of-Initial-Public-Offering-and-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares.html",
          "type": "url",
          "field": {
            "id": "B6l74SnKuwus",
            "ref": "cddedb92-f93e-4e05-9668-8df10ae4b10f",
            "type": "website"
          }
        },
        {
          "text": "San Diego",
          "type": "text",
          "field": {
            "id": "xE8fAQbqFvI9",
            "ref": "db540399-a6fe-4a58-999f-3c3f7e8424f6",
            "type": "short_text"
          }
        },
        {
          "type": "number",
          "field": {
            "id": "0abdNMcEMB7q",
            "ref": "24dcefe3-5de0-42c0-a7a3-e9063bdb4b78",
            "type": "number"
          },
          "number": 123000000
        },
        {
          "text": "BioTech",
          "type": "text",
          "field": {
            "id": "H3HzL7eCIUrM",
            "ref": "1ac8f4c0-3c66-4e9d-8b5d-16b79ac2cefd",
            "type": "short_text"
          }
        },
        {
          "url": "https://www.linkedin.com/company/codex-dna/",
          "type": "url",
          "field": {
            "id": "Rju42sot4Jgq",
            "ref": "5cc37dd3-49fa-490f-b383-59ad7ee435fc",
            "type": "website"
          }
        },
        {
          "url": "https://www.globenewswire.com/news-release/2021/06/22/2251361/0/en/Codex-DNA-Announces-Closing-of-Initial-Public-Offering-and-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares.html",
          "type": "url",
          "field": {
            "id": "9khp8F3EtXeU",
            "ref": "dd006de1-a354-4b3d-a124-11c038dfd997",
            "type": "website"
          }
        }
      ],
      "form_id": "qDBcLX6w",
      "landed_at": "2021-12-02T03:19:24Z",
      "definition": {
        "id": "qDBcLX6w",
        "title": "Make Event: IPO or Acquisition",
        "fields": [
          {
            "id": "q3QmKAzJYGzq",
            "ref": "b2eeb462-1500-4d36-a198-3de54ec14b00",
            "type": "short_text",
            "title": "Title",
            "properties": {}
          },
          {
            "id": "B7iC0k4GVJsg",
            "ref": "d2188e47-cf07-44d3-9e27-9be707573ec4",
            "type": "multiple_choice",
            "title": "What type of company event?",
            "choices": [
              {
                "id": "a3nPiLTDqcv0",
                "label": "IPO"
              },
              {
                "id": "XHN4Tuk7SYdX",
                "label": "Acquisition"
              }
            ],
            "properties": {},
            "allow_other_choice": true
          },
          {
            "id": "ba1GfT4AK1oH",
            "ref": "632265be-6f7a-47f2-8b55-54ddfce7d04d",
            "type": "date",
            "title": "When did this happen?",
            "properties": {}
          },
          {
            "id": "a0y0vsT8mzNv",
            "ref": "8790717a-44fe-4a19-9b83-671c89ac657d",
            "type": "long_text",
            "title": "Description",
            "properties": {}
          },
          {
            "id": "B6l74SnKuwus",
            "ref": "cddedb92-f93e-4e05-9668-8df10ae4b10f",
            "type": "website",
            "title": "Event Link",
            "properties": {}
          },
          {
            "id": "xE8fAQbqFvI9",
            "ref": "db540399-a6fe-4a58-999f-3c3f7e8424f6",
            "type": "short_text",
            "title": "Location",
            "properties": {}
          },
          {
            "id": "0abdNMcEMB7q",
            "ref": "24dcefe3-5de0-42c0-a7a3-e9063bdb4b78",
            "type": "number",
            "title": "Total Value",
            "properties": {}
          },
          {
            "id": "H3HzL7eCIUrM",
            "ref": "1ac8f4c0-3c66-4e9d-8b5d-16b79ac2cefd",
            "type": "short_text",
            "title": "Industry",
            "properties": {}
          },
          {
            "id": "Rju42sot4Jgq",
            "ref": "5cc37dd3-49fa-490f-b383-59ad7ee435fc",
            "type": "website",
            "title": "LINKEDIN URL of the acquired or IPO'd company.",
            "properties": {}
          },
          {
            "id": "9khp8F3EtXeU",
            "ref": "dd006de1-a354-4b3d-a124-11c038dfd997",
            "type": "website",
            "title": "Add any news article links here",
            "properties": {}
          }
        ]
      },
      "submitted_at": "2021-12-02T03:21:20Z"
    }
  },
  "created": "2021-12-02T03:21:22",
  "last_modified": "2021-12-02T03:21:22"
}
